Cargando…

Correction: Hyperprolactinemia with antipsychotic drugs in children and adolescents

Detalles Bibliográficos
Autor principal:	Rosenbloom, Arlan L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765950/ https://www.ncbi.nlm.nih.gov/pubmed/23958460 http://dx.doi.org/10.1186/1687-9856-2013-13

Ejemplares similares

Hyperprolactinemia with Antipsychotic Drugs in Children and Adolescents
por: Rosenbloom, Arlan L.
Publicado: (2010)

Management of antipsychotic-induced hyperprolactinemia
por: Tewksbury, Ashley, et al.
Publicado: (2016)

Antipsychotics-induced hyperprolactinemia and screening for macroprolactin
por: Ruljancic, Nedjeljka, et al.
Publicado: (2020)

Hormonal alterations due to antipsychotic-related hyperprolactinemia
por: Montejo, A.L., et al.
Publicado: (2022)

Hyperprolactinemia with antipsychotics and the need for magnetic resonance imaging
por: Molina Liétor, M.D.C., et al.
Publicado: (2022)

Reversal of symptomatic antipsychotic-induced hyperprolactinemia with addition of aripiprazole
por: Kotorki, Paraskevi, et al.
Publicado: (2010)

Association of ANKK1 polymorphism with antipsychotic‐induced hyperprolactinemia
por: Fedorenko, Olga Yu., et al.
Publicado: (2020)

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
por: Ishioka, Masamichi, et al.
Publicado: (2015)

Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia
por: Raveendranthan, Dhanya, et al.
Publicado: (2018)

Drug Induced Hyperprolactinemia
por: Venkatanarasu, Ashok, et al.
Publicado: (2021)

A Comment on “Add-on Aripiprazole for Atypical Antipsychotic-induced, Clinically Significant Hyperprolactinemia”
por: Naguy, Ahmed
Publicado: (2018)

Development of a Guideline for Antipsychotic-induced Hyperprolactinemia in Korea Using the ADAPTE Process
por: Kim, Hye Ri, et al.
Publicado: (2023)

The management of diabetic ketoacidosis in children
por: Rosenbloom, Arlan L.
Publicado: (2011)

Clinical and Laboratory Characteristics of Hyperprolactinemia in Children and Adolescents: National Survey
por: Eren, Erdal, et al.
Publicado: (2019)

Hyperprolactinemia in Children with Subclinical Hypothyroidism
por: Sharma, Neera, et al.
Publicado: (2017)

PM515. The association between serotonin receptor gene polymorphisms and hyperprolactinemia in antipsychotic drug-treated schizophrenic patients
por: Ivanova, Svetlana, et al.
Publicado: (2016)

Hyperprolactinemia
por: Majumdar, Abha, et al.
Publicado: (2013)

The Short-Term Effects of Risperidone-Induced Hyperprolactinemia on Lipid Metabolism in Drug-Naïve Children and Adolescents
por: Park, Eun Jin, et al.
Publicado: (2015)

PM403. Comparison between addition of and switching to aripiprazole for resolving antipsychotic-induced hyperprolactinemia
por: Lee, Jung Suk, et al.
Publicado: (2016)

Hyperprolactinemia in patients taking antipsychotics: the importance of a shared approach between psychiatry and endocrinology
por: Mousinho, M., et al.
Publicado: (2023)

Publisher Correction: Emergence of psychiatric adverse events during antipsychotic treatment in AP-naïve children and adolescents
por: Menard, Marie-Line, et al.
Publicado: (2023)

Clinical Course of Hyperprolactinemia in Children and Adolescents: A Review of 21 Cases
por: Eren, Erdal, et al.
Publicado: (2011)

Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone
por: Hongkaew, Yaowaluck, et al.
Publicado: (2015)

Adjunctive Aripiprazole Versus Placebo for Antipsychotic-Induced Hyperprolactinemia: Meta-Analysis of Randomized Controlled Trials
por: Li, Xianbin, et al.
Publicado: (2013)

Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions
por: Johnston, A. N., et al.
Publicado: (2018)

Pharmacological treatment strategies for antipsychotic-induced hyperprolactinemia: a systematic review and network meta-analysis
por: Lu, Zhe, et al.
Publicado: (2022)

Peony-Glycyrrhiza Decoction for Antipsychotic-Related Hyperprolactinemia in Patients with Schizophrenia: A Randomized Controlled Trial
por: Wang, Zhongbao, et al.
Publicado: (2023)

Teratogenicity and hyperprolactinemia
por: Andrade, Chittaranjan
Publicado: (2009)

Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trials
por: MENG, Meiling, et al.
Publicado: (2015)

Pharmacological causes of hyperprolactinemia
por: Torre, Daria La, et al.
Publicado: (2007)

Drug-induced Hyperprolactinemia Results in Atypical Atypical Fracture
por: Lee, Ingyu, et al.
Publicado: (2021)

Utility of Cannulated Prolactin to Exclude Stress Hyperprolactinemia in Patients with Persistent Mild Hyperprolactinemia
por: Almazrouei, Raya, et al.
Publicado: (2021)

Publisher Correction: Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment
por: Scheggia, Diego, et al.
Publicado: (2018)

Author Correction: Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics
por: Boloc, Daniel, et al.
Publicado: (2019)

Correction: Antipsychotic medications and stroke in schizophrenia: A case-crossover study
por: Chen, Wen-Yin, et al.
Publicado: (2019)

Recombinant Human Insulin-Like Growth Factor-1 Treatment: Prime Time or Timeout? [Commentary on “Recombinant Human Insulin Like Growth Factor-1 Treatment: Ready for Prime Time” by Bright GM, Mendoza JR, Rosenfeld RG, Endocrinol Metab Clin N Am 2009; 38:625–38]
por: Rosenbloom, Arlan L.
Publicado: (2009)

Idiopathic Short Stature: Conundrums of Definition and Treatment
por: Rosenbloom, Arlan L.
Publicado: (2009)

A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia
por: Osmanova, Diana Z., et al.
Publicado: (2019)

An Audit on the Monitoring and Management of Hyperprolactinemia in Inpatient Adults on Regular Antipsychotics in 8 Acute Wards in an NHS Mental Health Trust
por: Zhang, Peter, et al.
Publicado: (2022)

Correction: Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction)
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dsl6endvoqk5p0gdkbuvin4a8h